BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 28273828)

  • 41. Sleep, Cognitive impairment, and Alzheimer's disease: A Systematic Review and Meta-Analysis.
    Bubu OM; Brannick M; Mortimer J; Umasabor-Bubu O; Sebastião YV; Wen Y; Schwartz S; Borenstein AR; Wu Y; Morgan D; Anderson WM
    Sleep; 2017 Jan; 40(1):. PubMed ID: 28364458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral inflammatory biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis.
    Su C; Zhao K; Xia H; Xu Y
    Psychogeriatrics; 2019 Jul; 19(4):300-309. PubMed ID: 30790387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ASSOCIATION OF VITAMIN D WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DEMENTIA IN OLDER MEXICAN ADULTS.
    Aguilar-Navarro SG; Mimenza-Alvarado AJ; Jiménez-Castillo GA; Bracho-Vela LA; Yeverino-Castro SG; Ávila-Funes JA
    Rev Invest Clin; 2019; 71(6):381-386. PubMed ID: 31823966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S
    J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
    J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neutrophil to lymphocyte ratio in Alzheimer's disease: A systematic review and meta-analysis.
    Mohammadi A; Mohammadi M; Almasi-Dooghaee M; Mirmosayyeb O
    PLoS One; 2024; 19(6):e0305322. PubMed ID: 38917167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis.
    Li MM; Yu JT; Wang HF; Jiang T; Wang J; Meng XF; Tan CC; Wang C; Tan L
    Curr Alzheimer Res; 2014; 11(9):844-52. PubMed ID: 25274113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer's Disease: A Meta-Analysis.
    Xu LZ; Li FY; Li BQ; Cao SM; Li Y; Xu J; Jia JP
    J Alzheimers Dis; 2021; 82(3):1357-1367. PubMed ID: 34151815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood levels of circulating methionine components in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    Zhao Y; Dong X; Chen B; Zhang Y; Meng S; Guo F; Guo X; Zhu J; Wang H; Cui H; Li S
    Front Aging Neurosci; 2022; 14():934070. PubMed ID: 35936764
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decisional capacity to consent to treatment and research in patients affected by Mild Cognitive Impairment. A systematic review and meta-analysis.
    Parmigiani G; Del Casale A; Mandarelli G; Barchielli B; Kotzalidis GD; D'Antonio F; Di Vita A; de Lena C; Ferracuti S
    Int Psychogeriatr; 2022 Jun; 34(6):529-542. PubMed ID: 33583459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex differences in the prevalence and incidence of mild cognitive impairment: A meta-analysis.
    Au B; Dale-McGrath S; Tierney MC
    Ageing Res Rev; 2017 May; 35():176-199. PubMed ID: 27771474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HSV-1-Specific IgG Subclasses Distribution and Serum Neutralizing Activity in Alzheimer's Disease and in Mild Cognitive Impairment.
    Agostini S; Mancuso R; Hernis A; Costa AS; Nemni R; Clerici M
    J Alzheimers Dis; 2018; 63(1):131-138. PubMed ID: 29578484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort.
    Forti P; Olivelli V; Rietti E; Maltoni B; Pirazzoli G; Gatti R; Gioia MG; Ravaglia G
    Gerontology; 2012; 58(1):41-9. PubMed ID: 21430364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic Efficacy of Plasmalogens for Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease in Conjunction with a New Hypothesis for the Etiology of Alzheimer's Disease.
    Fujino T; Hossain MS; Mawatari S
    Adv Exp Med Biol; 2020; 1299():195-212. PubMed ID: 33417216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease.
    Kang S; Jeong H; Baek JH; Lee SJ; Han SH; Cho HJ; Kim H; Hong HS; Kim YH; Yi EC; Seo SW; Na DL; Hwang D; Mook-Jung I
    J Alzheimers Dis; 2016 Jul; 53(4):1563-76. PubMed ID: 27392853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
    Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
    J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutrophil activation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid.
    Wu CY; Bawa KK; Ouk M; Leung N; Yu D; Lanctôt KL; Herrmann N; Pakosh M; Swardfager W
    Ageing Res Rev; 2020 Sep; 62():101130. PubMed ID: 32712109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased apoptosis in the platelets of patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Zhao S; Zhao J; Zhang T; Guo C
    Clin Neurol Neurosurg; 2016 Apr; 143():46-50. PubMed ID: 26895209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.